ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,356.45
0.82%
Brent Oil
82.645
0.81%
Bitcoin
69,344.30
1.22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Valneva SE (VLA) Share Price

VLA Valneva SE

3.93
0.05 (1.29%)
Last Updated: 15:40:31
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Valneva SE EU:VLA Euronext Ordinary Share FR0004056851 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.05 1.29 3.93 3.924 3.928 3.948 3.868 3.914 224,610 14:40:31   
 Type  Size  Price  Time  Units 
  150 3.93 14:40:30 EUR
 
Recent News
DateTimeSource
HeadlineMore VLA News
21/05/202406:00GLOBEValneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur Scientifique
21/05/202406:00GLOBEValneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
21/05/202406:00GLOBEValneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
13/05/202406:00GLOBEValneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine
13/05/202406:00GLOBEValneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine
13/05/202406:00GLOBEValneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya
07/05/202406:00GLOBEValneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Period
Draw mode
Data Downloads for VLA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Valneva SE Articles